You are here

Mandatory information required in advertising for therapeutic goods

Decision tree

28 August 2019

This decision tree has been designed to help you identify what information you must include when advertising therapeutic goods to the public in order for the advertising to comply with the Therapeutic Goods Advertising Code (No.2) 2018 (the Code).

This information only applies to advertising more broadly. It does not capture labels or packaging, consumer medicine information leaflets, or patient information leaflets, the content of which is specified in other legislation. It also does not apply to 'picture/price/point-of-sale' advertisements - i.e. advertisements with a packshot, price and where the product can be purchased with no therapeutic claims visible or implied.

The decision tree will provide you with the minimum set of information required in your advertisement under the Code, based on the type of therapeutic good and the type of advertisement. You can include additional information in the advertisement if you wish, provided the minimum requirements are met.

Note that compliance with the minimum information requirements does not guarantee that your advertisement will fully comply with the Code and the advertising legislation more broadly. You will still need to review your advertising for compliance with all other relevant requirements in the Therapeutic Goods Act 1989 (the Act) and the Code.

Also note that under the Act and Code requirements:

  • representations that refer to serious forms of a disease, condition, ailment or defect are restricted representations and prior approval from the TGA will be required before you advertise the goods
  • advertisements for medicines intended to appear in 'specified media' (e.g. free-to-air television, radio, newspapers, magazines, billboards) require pre-approval.